MARYLAND STARTUP IMPROVES FLUORESCENCE-BASED MICROARRAYS FOR DISEASE DETECTION
Working with CNST NanoFab engineers, researchers from Plasmonix, Inc., have
built prototype plasmonic substrates for use in fluorescence-based microarrays. By allowing light to interact with metal nanoparticles, these plasmonic substrates increase the intensity of fluorophores (fluorescent molecules) by several orders of magnitude, improving the sensitivity of existing fluorescence-based protein microarray assays. Their device has the potential to expand the useful range of fluorescence for applications in clinical diagnostics and drug development without adding significant experimental time or operating costs.
Read more on attached PDF.
Working with CNST NanoFab engineers, researchers from Plasmonix, Inc., have
built prototype plasmonic substrates for use in fluorescence-based microarrays. By allowing light to interact with metal nanoparticles, these plasmonic substrates increase the intensity of fluorophores (fluorescent molecules) by several orders of magnitude, improving the sensitivity of existing fluorescence-based protein microarray assays. Their device has the potential to expand the useful range of fluorescence for applications in clinical diagnostics and drug development without adding significant experimental time or operating costs.
Read more on attached PDF.
